Detalles de la búsqueda
1.
Humoral and cellular immune responses to CoronaVac up to one year after vaccination.
Front Immunol
; 13: 1032411, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36341425
2.
Humoral and cellular immune responses to CoronaVac assessed up to one year after vaccination.
medRxiv
; 2022 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35821982
3.
Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
Trials
; 21(1): 853, 2020 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33059771
4.
Live, attenuated, tetravalent Butantan- Dengue vaccine in children and adults
N Engl J Med, v. 390, n. 5, fev. 2024.
Artículo
en Inglés
| SES-SP, SESSP-IBPROD, SES-SP | ID: bud-5248
5.
Humoral and cellular immune responses to CoronaVac up to one year after vaccination
Front Immunol, v. 13, 1032411, out. 2022
Artículo
en Inglés
| SES-SP, SESSP-IBPROD, SES-SP | ID: bud-4691
6.
Factors associated with the costs of palliative care: a retrospective cost analysis at a university Cancer hospital in Brazil
J Palliat Med, v. 24, n. 10, p. 1481-1488, set. 2021
Artículo
en Inglés
| SES-SP, SESSP-IBPROD, SES-SP | ID: bud-3624
Resultados
1 -
6
de 6
1
Próxima >
>>